Back
Mercury Systems 10K Form
Sell
35
MRCY
Mercury Systems
Last Price:
39.97
Seasonality Move:
9.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | MRCY/Mercury Systems Quarterly |
2024-02-06 | 10Q | MRCY/Mercury Systems Quarterly |
2023-11-07 | 10Q | MRCY/Mercury Systems Quarterly |
2023-05-09 | 10Q | MRCY/Mercury Systems Quarterly |
2023-02-07 | 10Q | MRCY/Mercury Systems Quarterly |
2022-11-08 | 10Q | MRCY/Mercury Systems Quarterly |
Receive MRCY News And Ratings
See the #1 stock for the next 7 days that we like better than MRCY
MRCY Financial Statistics
Sales & Book Value
Annual Sales: | $835.28M |
---|---|
Cash Flow: | $-20.9M |
Price / Cash Flow: | 44.3 |
Annual Sales: | $24.97 |
Price / Book: | 1.63 |
Profitability
EPS (TTM): | -2.04000 |
---|---|
Net Income (TTM): | $-118.46M |
Gross Margin: | $195.9M |
Return on Equity: | -7.95% |
Return on Assets: | -4.95% |
Mercury Systems Earnings Forecast
Key Mercury Systems Financial Ratios
- The Gross Profit Margin over the past 27 years for MRCY is 23.45%.
- The Selling, General & Administrative Expenses for MRCY have been equal to 19.97% of Gross Profit Margin.
- The Research & Development expenses have been 12.13% of Revenue.
- The Interest Expense is -25.44% of Operating Income.
- The Net Earning history of MRCY is -16.48% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 16 years.
Mercury Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Aerospace & Defense |
Sector: | Industrials |
Current Symbol: | MRCY |
CUSIP: | 589378 |
Website: | mrcy.com |
Debt
Debt-to-Equity Ratio: | 0.41 |
---|---|
Current Ratio: | 4.1 |
Quick Ratio: | 2.5 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 43.09 |
MRCY Technical Analysis vs Fundamental Analysis
Sell
35
Mercury Systems (MRCY)
is a Sell
Is Mercury Systems a Buy or a Sell?
-
Mercury Systems stock is rated a Sell
The current Mercury Systems [MRCY] share price is $38.92. The Score for MRCY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.